(Q33337475)

25 July 2017

title

A pilot study of whole body hyperthermia and carboplatin in platinum-resistant ovarian cancer (English)

1 reference

25 July 2017

1 reference

1 reference

1 reference

Westermann AM

1

1 reference

25 July 2017

Grosen EA

2

1 reference

25 July 2017

Katschinski DM

3

1 reference

25 July 2017

Jäger D

4

1 reference

25 July 2017

Rietbroek R

5

1 reference

25 July 2017

Schink JC

6

1 reference

25 July 2017

Tiggelaar CL

7

1 reference

25 July 2017

Jäger E

8

1 reference

25 July 2017

Zum Vörde sive Vörding P

9

1 reference

25 July 2017

Neuman A

10

1 reference

25 July 2017

Knuth A

11

1 reference

25 July 2017

Van Dijk JD

12

1 reference

25 July 2017

Wiedemann GJ

13

1 reference

25 July 2017

Robins HI

14

1 reference

25 July 2017

publication date

1 June 2001

1 reference

European Journal of Cancer

25 July 2017

published in

1 reference

25 July 2017

volume

37

1 reference

25 July 2017

issue

9

1 reference

25 July 2017

page(s)

1111-1117

1 reference

Tumoricidal interactions of hyperthermia with carboplatin, cisplatin and etoposide

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900074-0

7 January 2021

Thermal enhancement of tetraplatin and carboplatin in human leukaemic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900074-0

7 January 2021

Radiosensitization of C6 glioma by thymidine and 41.8 degrees C hyperthermia

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900074-0

7 January 2021

Whole body hyperthermia and carboplatin: cytotoxicity for murine leukaemia and normal marrow

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900074-0

7 January 2021

Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900074-0

7 January 2021

Sensitization of C6 glioma to carboplatin cytotoxicity by hyperthermia and thymidine.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900074-0

7 January 2021

Phase I clinical trial of carboplatin and 41.8 degrees C whole-body hyperthermia in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900074-0

7 January 2021

Cytokine Induction in Humans by 41.8 C WholeBody Hyperthermia

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900074-0

7 January 2021

Whole body hyperthermia cytokine induction: a review, and unifying hypothesis for myeloprotection in the setting of cytotoxic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900074-0

7 January 2021

Cytokine induction by 41.8 degrees C whole body hyperthermia

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900074-0

7 January 2021

Optimization of chemotherapy administration for clinical 41.8 degrees C whole body hyperthermia

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900074-0

7 January 2021

Carboplatin dosage: prospective evaluation of a simple formula based on renal function

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900074-0

7 January 2021

A new technological approach to radiant heat whole body hyperthermia

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900074-0

7 January 2021

Effect of hyperthermia in vitro and in vivo on adenine and pyridine nucleotide pools in human peripheral lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900074-0

7 January 2021

Relationships between carboplatin exposure and tumor response and toxicity in patients with ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900074-0

7 January 2021

10.1016/S0959-8049(01)00074-0

Identifiers

DOI

1 reference

25 July 2017

1 reference